fda glp-1 news november 2025 Weight-Loss Drug Demonstration Begins July 2026 New GLP-1 Pill Foundayo (Orforglipron)

Germany Glucagon Like Peptide-1 (GLP-1) Receptor Agonist Market is valued at around $575.5 Mn in 2022 and is projected to reach $974.1 Mn by 2030, exhibiting a CAGR of 6.8% during the forecast period 2023-2030

GLP-1 RA medications: What are they and how do they work Glucagon-like peptide-1 receptor agonists (GLP-1 RA) like Wegovy, Ozempic, and Saxenda, are a class of medications indicated for type 2 diabetes and obesity

Glucagon-like peptide-1 (GLP-1) receptor agonists have transformed type 2 diabetes and obesity management through proven effects on glucose control and weight reduction

Who Might Be a Candidate

They will also help you navigate school health requirements